期刊文献+

P-选择素对鉴别良恶性胸腔积液的意义 被引量:1

下载PDF
导出
摘要 目的检测结核性及恶性胸腔积液患者血清及胸腔积液中P-选择素水平,探讨其对鉴别良恶性胸腔积液的意义。方法采用ELISA法检测治疗前后50例结核性胸腔积液(结核性胸腔积液组)和50例恶性胸腔积液(恶性胸腔积液组)患者血清及胸腔积液中P-选择素水平。结果结核性胸腔积液组治疗前血清及胸腔积液中P-选择素分别为(7.17±4.89)、(7.58±5.21)μg/L,明显低于恶性胸腔积液患者[分别为(17.33±6.23)、(17.28±7.12)μg/L],P〈0.05;结核性胸腔积液组治疗后血清及胸腔积液中P-选择素分别为(3.36±1.29)、(3.45±1.34)μg/L,较治疗前明显降低,两组比较差异有统计学意义(P〈0.05);恶性胸腔积液患者治疗后血清及胸腔积液中P-选择素水平与治疗前比较差异无统计学意义。结论检测胸腔积液中P-选择素有助于良恶性胸腔积液的鉴别。
出处 《中国医师进修杂志(内科版)》 2009年第1期41-43,共3页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献5

  • 1Ludwig RJ, Alban S, Bistrian R, et al. The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo. Thromb Haemost, 2006,95 (3):535-540.
  • 2Ludwig R J, Boehme B, Podda M, et al. Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res, 2004,64(8):2743-2750.
  • 3Geng JG. Interaction of vascular endothelial cells with leukocytes, platelets and cancer cells in inflammation, thrombosis and cancer growth and metastasis. Acta Pharmacol Sin, 2003,24( 12):1297- 1300.
  • 4王英年,刘加洪,孙荣丽,李黎,官明德,于华,马学真,张春玲,赵云峰,王瑞兰.P-选择素等多项指标检测在胸腔积液鉴别中的应用价值[J].中国防痨杂志,2007,29(1):8-11. 被引量:2
  • 5Park K, Ki Lee S, Hyun Son D, et al. The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative. Biomaterials, 2007,28( 16):2667-2676.

二级参考文献15

  • 1Stone JP,Wagner DD.P-selectin mediate adhesion of platelet to neuroblastion and cancer cell[J].J Clin Invest,1993,92 (2):804-810.
  • 2Dunlop LC,Skinner MP,Bendall LJ,et al.Characterization of GMP-104(P-selectin) as a circulating plasma protein[J].J EXP Med,1992,175:1147-1151.
  • 3Brock TA,Dvorak -HF,Senger DR,et al.Tumor-secreted vascular permeability factor increase cytosolic ca^2+ and Von Willebrand factor release in human endothelial cells[J].AmJ Pathol,1995,138 (1):213-221.
  • 4Mantovani G,Maccio A,Pisano M,et al.Tumor-associated lymphomonocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines[J].Int J Cancer,1997,71:724-731.
  • 5Hirsch CS,Toossi Z,Johnson JL,et al.Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis[J].J Infect Dis,2001,183 (5):779 -788.
  • 6Schulze O K,Ferrari D,Los M,et al.Apoptosis signaling by deatn factots[J].Eur J Biochem,1998,254(3):439-459.
  • 7Cheng J,zhou T,Liu C,et,al.Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule[J].Science,1994,263(5154):1759-1762.
  • 8Suda T,Tanaka M,Miwa K,et al.Apoptosis of mouse native T cells induced by recombinant soluble Fas Ligand and activation induced resistance to Fas Ligand[J].J Immunol,1996,157:3918.
  • 9Oddo,M; Renno,T; Attinger,A,et al.Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis[J].J Immunol,1998,160(11):5448-5450.
  • 10Mustafa,T;BjuneT,G;Jonsson,R,et al.Increased expression of Fas ligand in human tuberculosis and leprosy lesions:a potential novel mechanism of immune evasion in mycobacterial infection[J].Scand-J-b Immunol,2001,54(6):630-639.

共引文献1

同被引文献19

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部